Operation Warp-Pay: How 10b5-1 Plans Allowed Pfizer and Moderna Executives to Cash In

With Pfizer and Moderna’s COVID-19 vaccines in the headlines, the companies’ executive teams have also attracted attention because of the sizeable stock sales they benefitted from after positive trial developments were announced. Although the timing [...]

By |2021-04-08T14:50:41-07:00January 21, 2021|Blog|Comments Off on Operation Warp-Pay: How 10b5-1 Plans Allowed Pfizer and Moderna Executives to Cash In

Proxy Season Insider: April 17

Important highlights from upcoming meetings, provided by Glass Lewis' global research team Bezeq the Israel Telecommunication Corp. Ltd. Tel-Aviv Stock Exchange – April 26 There is already little doubt that Bezeq's 2018 annual meeting, which [...]

By |2021-04-08T14:52:47-07:00April 17, 2018|Blog|Comments Off on Proxy Season Insider: April 17

Proxy Season Insider: April 17

Highlights from the world of Proxy Papers you can’t afford to miss! Credit Suisse Group SIX Swiss Exchange – April 25 After a painful year of restructuring, Credit Suisse is hoping its upcoming AGM will offer [...]

By |2021-04-08T14:53:47-07:00April 17, 2017|Blog|Comments Off on Proxy Season Insider: April 17